Biotest Aktiengesellschaft (BIO) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.114x

Based on the latest financial reports, Biotest Aktiengesellschaft (BIO) has a cash flow conversion efficiency ratio of -0.114x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-58.10 Million ≈ $-67.93 Million USD) by net assets (€509.60 Million ≈ $595.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BIO net asset quality score to measure how much of total assets are equity-financed.

Biotest Aktiengesellschaft - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Biotest Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Biotest Aktiengesellschaft's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Biotest Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biotest Aktiengesellschaft ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Xiangyu Medical Co. Ltd. A SHG:688626	0.009x
Capitol Federal Financial Inc NASDAQ:CFFN	0.017x
Lemon Tree Hotels Limited NSE:LEMONTREE	0.113x
Delong Composite Energy Group Co Ltd SHE:000593	0.009x
Whitestone REIT NYSE:WSR	0.008x
Brookline Bancorp Inc NASDAQ:BRKL	0.027x
Beijing CTJ Information Technology Co. Ltd. SHE:301153	N/A
Guanglian Aviation Industry Co Ltd SHE:300900	-0.015x

Annual Cash Flow Conversion Efficiency for Biotest Aktiengesellschaft (2002–2024)

The table below shows the annual cash flow conversion efficiency of Biotest Aktiengesellschaft from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see BIO market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€530.70 Million ≈ $620.44 Million	€60.90 Million ≈ $71.20 Million	0.115x	+2220.40%
2023-12-31	€498.90 Million ≈ $583.27 Million	€-2.70 Million ≈ $-3.16 Million	-0.005x	+95.04%
2022-12-31	€371.10 Million ≈ $433.85 Million	€-40.50 Million ≈ $-47.35 Million	-0.109x	-222.46%
2021-12-31	€380.40 Million ≈ $444.73 Million	€33.90 Million ≈ $39.63 Million	0.089x	+335.65%
2020-12-31	€441.60 Million ≈ $516.28 Million	€-16.70 Million ≈ $-19.52 Million	-0.038x	+46.32%
2019-12-31	€476.90 Million ≈ $557.55 Million	€-33.60 Million ≈ $-39.28 Million	-0.070x	+30.22%
2018-12-31	€495.20 Million ≈ $578.94 Million	€-50.00 Million ≈ $-58.46 Million	-0.101x	-202.38%
2017-12-31	€347.80 Million ≈ $406.61 Million	€34.30 Million ≈ $40.10 Million	0.099x	-46.02%
2016-12-31	€360.70 Million ≈ $421.70 Million	€65.90 Million ≈ $77.04 Million	0.183x	+97.71%
2015-12-31	€412.30 Million ≈ $482.02 Million	€38.10 Million ≈ $44.54 Million	0.092x	+489.25%
2014-12-31	€480.20 Million ≈ $561.40 Million	€-11.40 Million ≈ $-13.33 Million	-0.024x	-51.90%
2013-12-31	€460.70 Million ≈ $538.61 Million	€-7.20 Million ≈ $-8.42 Million	-0.016x	-116.63%
2012-12-31	€369.43 Million ≈ $431.91 Million	€34.73 Million ≈ $40.60 Million	0.094x	-54.92%
2011-12-31	€346.67 Million ≈ $405.29 Million	€72.28 Million ≈ $84.50 Million	0.208x	-17.59%
2010-12-31	€307.61 Million ≈ $359.63 Million	€77.83 Million ≈ $90.99 Million	0.253x	+115.51%
2009-12-31	€269.86 Million ≈ $315.50 Million	€31.68 Million ≈ $37.04 Million	0.117x	-13.75%
2008-12-31	€253.37 Million ≈ $296.22 Million	€34.49 Million ≈ $40.32 Million	0.136x	-5.47%
2007-12-31	€225.76 Million ≈ $263.94 Million	€32.51 Million ≈ $38.01 Million	0.144x	-1.85%
2006-12-31	€179.31 Million ≈ $209.64 Million	€26.31 Million ≈ $30.76 Million	0.147x	-12.46%
2005-12-31	€168.97 Million ≈ $197.55 Million	€28.32 Million ≈ $33.11 Million	0.168x	-28.46%
2004-12-31	€107.97 Million ≈ $126.22 Million	€25.29 Million ≈ $29.57 Million	0.234x	+46.49%
2003-12-31	€103.29 Million ≈ $120.75 Million	€16.52 Million ≈ $19.31 Million	0.160x	+619.93%
2002-12-31	€110.79 Million ≈ $129.53 Million	€2.46 Million ≈ $2.88 Million	0.022x	--

About Biotest Aktiengesellschaft

XETRA:BIO Germany

Market Cap

$976.15 Million

€834.96 Million EUR

Market Cap Rank

#8907 Global

#1153 in Germany

Share Price

€42.20

Change (1 day)

+0.00%

52-Week Range

€42.20 - €42.20

All Time High

€44.10